Diagnosis and Management of Helicobacter pylori Infection

Non-Invasive Diagnostic Methods

The American Gastroenterological Association recommends the urea breath test (UBT) and stool antigen test as the preferred non-invasive diagnostic methods for H. pylori infection, with UBT demonstrating sensitivity of 94-97% and specificity of 95%, and stool antigen test showing sensitivity and specificity of approximately 93% 1, 2
The urea breath test (UBT) is considered the most accurate non-invasive test for H. pylori, detecting active infection by measuring urease activity 1, 2
Laboratory-based validated monoclonal stool antigen test directly detects H. pylori bacterial antigens in stool specimens with comparable accuracy to UBT 1, 2

Histological examination requires at least two biopsy samples from the antrum and body for improved sensitivity 2
Rapid urease test (RUT) has pre-treatment sensitivity of 80-95% with specificity of 95-100%, requiring approximately 10^4 organisms for a positive result 2, 3
Culture provides definitive proof of infection and allows for antimicrobial susceptibility testing, particularly valuable after treatment failure when antimicrobial resistance is suspected 2

For young (<50 years) dyspeptic patients without alarm symptoms, the European Society for Primary Care Gastroenterology recommends using UBT or laboratory-based monoclonal stool antigen test 1, 4
For patients with alarm symptoms (bleeding, weight loss, dysphagia, palpable mass) or age ≥50 years with new-onset dyspepsia, the American College of Gastroenterology recommends performing endoscopy with invasive testing 1

Testing should be performed no earlier than 4 weeks after completion of treatment, according to the American Gastroenterological Association 1
The American College of Gastroenterology recommends using UBT or stool antigen test for confirmation of eradication, never serology 1

Proton pump inhibitors should be stopped for at least 2 weeks before testing by culture, histology, rapid urease test, UBT, or stool test to avoid false-negative results, as recommended by the European Helicobacter Study Group 1, 2
Antibiotics should be discontinued at least 4 weeks before testing, according to the American Gastroenterological Association 2
For patients who have failed eradication therapy, especially when antimicrobial resistance is suspected, the European Society for Primary Care Gastroenterology recommends endoscopy with culture and susceptibility testing 1, 2

The American College of Cardiology Foundation and American College of Gastroenterology report specificity exceeding 90% for the stool antigen test in initial diagnosis, with the monoclonal antibody version achieving approximately 93-97% specificity 5, 6, 7, 8
The polyclonal stool antigen test demonstrates a specificity of 93.2% in untreated patients based on weighted analysis of 3,419 patients evaluated before therapy 6

Specificity drops to 87.6% when using the polyclonal test for confirmation of eradication 4-8 weeks after treatment 6

The urea breath test achieves slightly higher specificity of 95-97.7% compared to stool antigen testing 6
Serologic antibody tests have lower specificity of approximately 90% and cannot distinguish active from past infection 5, 7
Rapid urease testing from endoscopic biopsies demonstrates specificity of 95-100% but requires invasive procedures 6, 9